as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.88%
Downside
3.46%
Upside
52 Week's Low
52 Week's High
27.10%
Downside
25.41%
Upside
Check Xenon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.7B
EPS (TTM)
-4.2949
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.61
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
-0.06
EBITDA
-315.5M
Revenue (TTM)
7.5M
Profit Margin
0.00%
Return On Equity TTM
141433900.00%
Track how Xenon Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Xenon Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Today (-18.61x)
September 18, 2025
Industry (10.13x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: -18.61x
Compare market cap, revenue, PE, and other key metrics of Xenon Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.7B | 211.71% | -18.61 | 0.00% | |
BUY | $60.5B | 248.74% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Xenon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Xenon Pharmaceuticals Inc investment value today
Current value as on today
₹96,092
Returns
Returns from Xenon Pharmaceuticals Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 24 analysts
95.83%
Buy
4.17%
Hold
0.00%
Sell
Based on 24 analysts, 95.83% of analysts recommend a 'BUY' rating for Xenon Pharmaceuticals Inc. Average target price of $54.95
Get share price movements and forecasts by analysts on Xenon Pharmaceuticals Inc.
What analysts predicted
33.25%UPSIDE
Target Price
$54.95
Current Price
$36.68
Analyzed by
24 Analysts
Target
$54.95
Xenon Pharmaceuticals Inc target price $54.95, a slight upside of 33.25% compared to current price of $36.68. According to 24 analysts rating.
Search interest for Xenon Pharmaceuticals Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:11% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 2.51M → 7.5M (in $), with an average increase of 66.5% per quarter
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 76.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 113.1%
Profit Down
Netprofit is down for the last 2 quarters, -65.04M → -84.70M (in $), with an average decrease of 30.2% per quarter
Price Dip
In the last 1 month, XENE stock has moved down by -3.0%
Organisation | Xenon Pharmaceuticals Inc |
Headquarters | 200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 |
Industry | Health Technology |
CEO | Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Darren S. Cline M.B.A. | Chief Commercial Officer and Member of Executive Team |
Mr. Ian C. Mortimer C.M.A., CPA, M.B.A. | Interim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director |
Ms. Andrea DiFabio J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Christopher John Kenney M.D. | Chief Medical Officer |
Dr. Matthew D. Ronsheim Ph.D. | Chief Operating Officer |
Ms. Shelley McClCoskey B.A. | Executive Vice President of Human Resources |
Dr. Robin P. Sherrington Ph.D. | Executive Vice President of Strategy & Innovation |
Dr. James R. Empfield Ph.D. | Executive Vice President of Drug Discovery |
Xenon Pharmaceuticals Inc share price today is $36.68 as on at the close of the market. Xenon Pharmaceuticals Inc share today touched a day high of $37.95 and a low of $35.99.
Xenon Pharmaceuticals Inc share touched a 52 week high of $46 on and a 52 week low of $26.74 on . Xenon Pharmaceuticals Inc stock price today i.e. is closed at $36.68,which is 20.26% down from its 52 week high and 37.17% up from its 52 week low.
Xenon Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Xenon Pharmaceuticals Inc (XENE) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Xenon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Xenon Pharmaceuticals Inc share’s latest price of $36.68 as on September 18, 2025 at 1:29 am IST, you will get 0.2726 shares of Xenon Pharmaceuticals Inc. Learn more about
fractional shares .
Xenon Pharmaceuticals Inc stock has given 211.71% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?